Stay updated with breaking news from Michael Schotsaert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- In some patients, infection with the pandemic virus SARS-CoV-2 can trigger a dangerous immune response in hardened fatty deposits (plaques)...
The RNA adjuvant triggers antiviral pathways inside the cell
While much of the global concern has subsided, COVID-19 is still a very real threat, especially to people with compromised immune systems or who are over 65.
While vaccines are known to offer protection against serious illness and death, vaccines can be improved in their ability to stop the spread of SARS-CoV-2 at the point of entry in the upper respiratory tract, the research led by the University of Michigan (U-M) and the Icahn School of Medicine at Mount Sinai, US, said
A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops COVID infection in both young and old mice.